Cancer and radiosensitivity syndromes: is impaired nuclear atm kinase activity the primum movens?

HIGHLIGHTS

• who: Laura El Nachef et al. from the Inserm, Unit, Radiation: Defense, Health and Environment, Centre Lu00e9on-Bu00e9rard, Lyon, France have published the research: Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?, in the Journal: Cancers 2022, 14, 6141. of /2022/
• what: The model may be completed with mechanisms describing the fate of the DNA damage when induced during the G2/M phase.
• how: While these two requirements involve two different functions that should be both impaired the review shows that the major cancer and radiosensitivity syndromes are . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.